Equity Mates Investing Podcast cover image

Andrew Brown reviews his 2025 bold predictions

Equity Mates Investing Podcast

00:00

Novo Nordisk: a major miss

Andrew admits his worst call on Novo Nordisk, examining pricing pressure, management changes, and Eli Lilly's outperformance.

Play episode from 21:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app